- Corporate Officers - D
- Degnan Chris
Insider Trading History of Degnan Chris
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Degnan Chris since 2018.
This trader's CIK number is 1741968.
At the time of last reporting, Degnan Chris was the Chief Financial Officer of Urogen Pharma Ltd.. (stock ticker symbol URGN).
Also see all insider trading activities at Urogen Pharma Ltd..
Note that in the past
Degnan Chris also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Galera Therapeutics, Inc. (GRTX) by Degnan Chris
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | GRTX | 10,000 | $19,590 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Urogen Pharma Ltd. (URGN) by Degnan Chris
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | URGN | 0 | $0 | 2,203 | $37,120 | 4,483 | $0 |
Yearly summary of insider trading at Verrica Pharmaceuticals Inc. (VRCA) by Degnan Chris
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | VRCA | 3,000 | $45,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Degnan Chris:
1. Galera Therapeutics, Inc. (GRTX)
2. Urogen Pharma Ltd. (URGN)
3. Verrica Pharmaceuticals Inc. (VRCA)
Table 1. Insider trading of Galera Therapeutics, Inc. (GRTX) by Degnan Chris
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-03-13 | GRTX | Buy | 10,000 | 1.96 | 19,590 |
Table 2. Insider trading of Urogen Pharma Ltd. (URGN) by Degnan Chris
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-10-08 | URGN | Sale | 2,203 | 16.85 | 37,120 |
| 2025-10-08 | URGN | Option Ex | 4,483 | .00 | 0 |
Table 3. Insider trading of Verrica Pharmaceuticals Inc. (VRCA) by Degnan Chris
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-06-19 | VRCA | Buy | 3,000 | 15.00 | 45,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Degnan Chris
(Chief Financial Officer of Urogen Pharma Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.